Intestinal parasitosis is a common complication in thalassemic patients. Although it is rare, it can be serious. Intestinal parasites are a major cause of morbidity and mortality worldwide, especially in the developing world. They can cause chronic diarrhea, weakened immunity, and can even be fatal. Fortunately, many preventable intestinal infections can be prevented, such as constipation.
Intestinal parasitosis is a common condition among thalassemic patients, affecting approximately 1 in 50 people. The most common species is the Blastocystis, followed by Entamoeba coli, Chilomastix mesnili, and Strongyloides stercoralisi. The highest rates were seen among thalassemic patients with CD4 counts under 200 cells/mL. Despite their low incidence, it can cause diarrhea and anorexia, especially in individuals with poor immune systems.
The study’s results show that the highest incidence of intestinal parasites is in thalassemic children. However, it is possible that intestinal parasites are more common in patients with low CD4 counts and anemia. ART can also lower the incidence of parasitic infections. This finding supports the importance of preventing infection in thalassemic children. It can also be linked to poor recovery, high viral load, and increased prevalence of autoimmune diseases.
Intestinal parasites in thalassemic children is uncommon in adults. This could be due to geographic differences in the populations and sample sizes. Likewise, the prevalence of these infections is much lower than in HIV/AIDS patients. This may be the result of increased awareness of the disease and the adherence to antiretroviral therapy (ART). The low rate of intestinal parasites in thalassemic children reflects the importance of prevention in thalassemic diseases.
The study found that the prevalence of intestinal parasites among thalassemic children and adults was low in comparison to controls. Intestinal parasites were found to be more common in patients with a low CD4 count and anemia. The parasites were also more common in those with a low CD4 count. Overall, thalassemic patients were more likely to have abdominal pain, diarrhea, and anemia.
Intestinal parasites are frequently found in thalassemic children. The most common was Endolimax nana, which represented 14.4% of all thalassemia cases. The parasites were associated with lower hemoglobin levels and anemia. There were no significant correlations between the presence of intestinal parasites and high viral load. It is important to ensure that these patients are not immune to other intestinal infections.
Intestinal parasites are also a common complication in thalassemic children. They can cause thrombocytopenia and can affect the immune system. They can lead to death in patients with cancer. For this reason, it is essential to identify the parasites in these children before they cause any harm. Intestinal parasites can cause irreparable effects on cancer patients. This is why thalassemic children should be closely monitored and treated for intestinal parasites.